Business Description
Annji Pharmaceutical Co Ltd
ISIN : TW0007754004
Total Employee Number:
34Description
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.06 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 7.78 | |||||
Beneish M-Score | 2.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 47.4 | |||||
3-Year EBITDA Growth Rate | -3.8 | |||||
3-Year EPS without NRI Growth Rate | -1.8 | |||||
3-Year FCF Growth Rate | -8.9 | |||||
3-Year Book Growth Rate | -14.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.8 | |||||
9-Day RSI | 40.06 | |||||
14-Day RSI | 40.06 | |||||
3-1 Month Momentum % | -5.32 | |||||
6-1 Month Momentum % | 20.73 | |||||
12-1 Month Momentum % | 84.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.6 | |||||
Quick Ratio | 3.42 | |||||
Cash Ratio | 3.39 | |||||
Days Inventory | 1409.77 | |||||
Days Sales Outstanding | 5.25 | |||||
Days Payable | 64.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.65 | |||||
Operating Margin % | -4891.01 | |||||
Net Margin % | -4738.73 | |||||
EBITDA Margin % | -4119.53 | |||||
FCF Margin % | -4687.76 | |||||
OCF Margin % | -4638.31 | |||||
ROE % | -71.95 | |||||
ROA % | -45.19 | |||||
ROIC % | -115.47 | |||||
3-Year ROIIC % | 731.2 | |||||
ROC (Joel Greenblatt) % | -494.77 | |||||
ROCE % | -57.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 691.14 | |||||
PB Ratio | 16.19 | |||||
Price-to-Tangible-Book | 20.45 | |||||
EV-to-EBIT | -14.63 | |||||
EV-to-EBITDA | -16.74 | |||||
EV-to-Revenue | 690.17 | |||||
EV-to-FCF | -15.89 | |||||
| Price-to-Net-Current-Asset-Value | 52 | |||||
| Price-to-Net-Cash | 66.59 | |||||
Earnings Yield (Greenblatt) % | -6.84 | |||||
FCF Yield % | -6.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Annji Pharmaceutical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 7.552 | ||
| EPS (TTM) (NT$) | -3.781 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 55.39 | ||
| 14-Day RSI | 40.06 | ||
| 14-Day ATR (NT$) | 2.47691 | ||
| 20-Day SMA (NT$) | 58.89 | ||
| 12-1 Month Momentum % | 84.87 | ||
| 52-Week Range (NT$) | 31.454079 - 71.2 | ||
| Shares Outstanding (Mil) | 100.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Annji Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Annji Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Annji Pharmaceutical Co Ltd Frequently Asked Questions
What is Annji Pharmaceutical Co Ltd(ROCO:7754)'s stock price today?
The current price of ROCO:7754 is NT$54.60. The 52 week high of ROCO:7754 is NT$71.20 and 52 week low is NT$31.45.
When is next earnings date of Annji Pharmaceutical Co Ltd(ROCO:7754)?
The next earnings date of Annji Pharmaceutical Co Ltd(ROCO:7754) is .
Does Annji Pharmaceutical Co Ltd(ROCO:7754) pay dividends? If so, how much?
Annji Pharmaceutical Co Ltd(ROCO:7754) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Annji Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers